Name: | Description: | Size: | Format: | |
---|---|---|---|---|
242.31 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Atherosclerotic cardiovascular disease (ASCVD) is a global health challenge, prompting widespread use of conventional risk assessment tools (SCORE2 in Europe and the ASCVD Risk calculator in the United States) to guide preventive strategies. Emerging evidence indicates that high-sensitivity cardiac troponin (hsTn) may refine risk stratification.
Description
Keywords
Citation
Publisher
Oxford University Press